Back

Comorbidities and risk of death in atrial fibrillation: a nationwide cohort study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: what is associated with mortality? Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Aapo Aro

Helsinki University Hospital, Helsinki (Finland)

7 More presentations in this session

Presentation thumbnail
Racial and ethnic disparities in the incidence of stroke and mortality in atrial fibrillation: a US nationwide study
Assistant Professor U. Essien (Los Angeles, US)
Abstract Slides Video
Presentation thumbnail
Cognitive patterns according to mini-mental state examination domains in patients with AF and association with all-cause mortality: a cluster analysis from a contemporary prospective study
Doctor M. Vitolo (Modena, IT)
Abstract Slides Video
Presentation thumbnail
A 3-year retrospective exploration of predictors for cardiac arrest in atrial fibrillation
Doctor A. Brgdar (Washington, US)
Abstract Slides Video
Presentation thumbnail
Screening for Atrial Fibrillation (AF) by handheld single-lead ECG and risk of all-cause mortality stratified by non-AF cardiovascular disease
Doctor W. Sun (Shatin, HK)
Abstract Slides Video
Presentation thumbnail
The gender difference in cause of death in Japanese atrial fibrillation patients: The Fushimi AF Registry
Doctor K. Doi (Kyoto, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: what is associated with mortality?

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Multimorbidity increases risk of cardiovascular outcomes in permanent atrial fibrillation: data from the RACE II study
thumbnail
Congress Presentation
Permanent and persistent atrial fibrillation are independent risk factors of mortality after severe COVID-19
thumbnail
Congress Presentation
Multimorbidity increases risk of atrial fibrillation recurrence after cryoballoon ablation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources